| Name | Title | Contact Details |
|---|
Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.
The MetroHealth System is an essential health system committed to providing health care to everyone in Cuyahoga County, Ohio, and improving the health of the community overall. Its 6,700 employees deliver care to everyone at its main campus, just west of downtown Cleveland, and at more than 20 other MetroHealth locations. It also provides health care at more than 20 additional sites in Cuyahoga County through community partnerships such as the School Health Program. MetroHealth is home to Cuyahoga County`s only verified Level I Adult Trauma Center and Level II Pediatric Trauma Center, and it is the only adult and pediatric burn center in the state of Ohio verified by the American Burn Association and the Committee on Trauma of the American College of Surgeons. In the past year, MetroHealth provided more than one million patient visits in its hospital and health centers. MetroHealth also is an academic medical center committed to teaching and research; each of its active physicians holds a faculty appointment at Case Western Reserve University School of Medicine. MetroHealth has earned Magnet status, which places it in the top 6 percent of all hospitals nationwide for nursing excellence. The MetroHealth System makes every effort to ensure that in every phase of the recruitment and selection process, equal employment is provided to all individuals, regardless of race, color, gender, sex, age, creed, disability, national origin or citizenship, veteran`s status, sexual orientation, gender identity, religious affiliation, socio-economic standing, pregnancy and/or genetic information, and any other protected characteristic. MetroHealth`s mission is, “Leading the way to a healthier you and a healthier community through service, teaching, discovery and teamwork.”
FOI Services is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.
Affinity Benefit Services is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.